AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇹🇿

Bevacizumab in Tanzania

9 products registered with TMDA 9 active

Brand / ProductReg. No.HolderStatusExpires
Avastin
Injection
TAN 09,014 V03A FLRF.Hoffmann-La Roche Limitedactive
BEVAAS 100
Solution for injection
TZ 19 H 0239HETERO BIOPHARMA LIMITEDactive
BEVAAS 400
Solution for injection
TZ 19 H 0240HETERO BIOPHARMA LIMITEDactive
KRABEVA 100mg/4ml
Solution for injection/concentrate for solution for infusion
TAN 23 V 0616Biocon Biologics UK Limitedactive
KRABEVA 400mg/16mL
Solution for injection/concentrate for solution for infusion
TAN 23 HM 0617Biocon Biologics UK Limitedactive
Abevmy™ 400
Solution for injection/concentrate for solution for infusion
TZ 19 H 0174Biosimilars Newco Limited (BNCL)active
BEVAMAB 400
Intravenous Infusion
TAN 20 HM 0411Intas Pharmaceuticals Ltdactive
Abevmy™ 100
Solution for injection/concentrate for solution for infusion
TZ 19 H 0175Biosimilars Newco Limited (BNCL)active
BEVAMAB
Solution for injection/concentrate for solution for infusion
TAN 22 HM 0107Intas Pharmaceuticals Ltdactive

BevacizumabTMDA Registration Details

TMDA (Tanzania) has 9 registered products containing Bevacizumab, of which 9 are currently active. Data is sourced directly from the official TMDA drug register and refreshed daily.

Track Bevacizumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.